In hindsight it was a very good decision seeing where the SP is now and the lack of progress the P3 trial has made.
I was concerned at the time when seeing how unnecessarily widespread it was set up to be so I chose to reduce. The SP is now a lot lower than when I sold that bunch.
I'm very glad with the profit I've made with my investment here. I wish the company was further along as both an investor and a human wanting to see any help in the fight against COVID-19. I also wish the company all the best in the future despite my reduction and that hope it will reach it's goal eventually.
What I fail to see why you need to make comments such as those.
This is not a deramping message either but just my opinion and it won't effect the SP.
I reduced my holding by 50% when the P3 was announced as I felt the concept of it was far too ambitious and time consuming.
I further reduced to 30% holding when RM made the "put out a fire" remark.
And reduced down to 10% of my original holding yesterday morning after reading the RNS which was not good, IMO. I thought it would open 20% down but to my surprise it took a while to drop which allowed me to sell. The remaining 10% are at a 34p average and I'll reassess on Tuesday what to do with them but I won't be adding.
I've always thought it was for a targeted population and why I thought, like others here, that the HT results would fail to meet the endpoints. As it did.
There has been a lot of yelling back and forth by "rampers" and "derampers" but in the end I think RM is the one who should answer for this. The P3 trial has turned into a red tape nightmare which is looking to be further delayed and that's on his shoulders. I'm disheartened because any treatment against COVID-19 is needed now but this won't be anywhere anytime soon which is why they were so glum in the presentation. That's not deramping, it's sadly what the situation is.
I wish everyone the best and really hope it will work out in the end.
“As Governments around the world , such as India, look to how future outbreaks and variants may be handled , our virus-agnostic therapeutic could help to save lives, release pressure on the world’s healthcare systems , and thereby potentially mitigate the need for economically costly lockdowns.”
The RNS does not say they are talking to India. It just mentions India as one of the world's governments.